Bettina Werle–Lapostolle

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆

Bettina Werle–Lapostolle, Scott Bowden, Stephen Locarnini et al. · Gastroenterology · 2004 · 895 citations · Full text

Hepatitis D, Hepatology, Hepatitis C +14

A new strategy for studyingIn Vitro the drug susceptibility of clinical isolates of human hepatitis B virus

David Durantel, Sandra Carrouée‐Durantel, Bettina Werle–Lapostolle et al. · Hepatology · 2004 · 86 citations

Immunology, Hepatitis B, Pathology +16

A new strategy for studyingin vitro the drug susceptibility of clinical isolates of human hepatitis B virus

David Durantel, Sandra Carrou�e-Durantel, Bettina Werle–Lapostolle et al. · Hepatology · 2004 · 77 citations

Suboptimal Response to Adefovir Dipivoxil Therapy for Chronic Hepatitis B in Nucleoside-Naive Patients is not due to Pre-Existing Drug-Resistant Mutants

Sandra Carrouée‐Durantel, David Durantel, Bettina Werle–Lapostolle et al. · Antiviral Therapy · 2008 · 44 citations · Full text

DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection

Alexandre Thermet, Thierry Buronfosse, Bettina Werle–Lapostolle et al. · Journal of General Virology · 2008 · 24 citations